Viewing nowCombinationAlcur Tablet
Ranitidine Hydrochloride 84mg · Tripotassium Bismuth Dicitrate 100mg +1 more
Tablet · Prescription medication · Combination
Ilhwa Co., Ltd.

MFDS item code 201504119 · Approved 2015.06.24
This product's status changed to Expired on 2025.06.24. It may no longer be sold, so consult a doctor or pharmacist before taking it.
Treatment of acid-related disorders (e.g., ulcers and gastritis) and prevention of Mendelson's syndrome
This medication is used for gastric and duodenal ulcers, gastritis, gastroesophageal reflux disease, Zollinger-Ellison syndrome, and other gastrointestinal disorders. It is particularly helpful in treating ulcers caused by non-steroidal anti-inflammatory drugs. It is also used to prevent ulcers after surgery and to prevent Mendelson's syndrome before anesthesia. This medication regulates gastric acid secretion to protect the stomach lining and promote ulcer healing. Therefore, it improves gastrointestinal health and is used for the treatment of various gastrointestinal diseases.
○ Adults The usual dose is 2 tablets orally twice daily, in the morning and at bedtime, regardless of meals. 1) Gastric and duodenal ulcers Administer 2 tablets twice daily or 4 tablets once daily at bedtime. In particular, a higher healing rate may be achieved in patients with duodenal ulcers by administering 4 tablets twice daily, in the morning and at bedtime. The same dosage applies to combination therapy to treat ulcers caused by nonsteroidal anti-inflammatory drugs (NSAIDs) or to prevent gastric and duodenal ulcers during long-term NSAID therapy. NSAID-induced conditions usually heal within 4 weeks, and ulcers usually heal within 8 weeks, although the healing period may occasionally be longer in some patients. For patients with recurrent ulcers who responded well to short-term treatment with this medicine, administer 2 tablets once daily at bedtime for maintenance therapy. 2) Gastroesophageal reflux disease Administer 2 tablets twice daily for 8 weeks or 4 tablets once daily at bedtime. However, the dose may be increased to 4 tablets 4 times daily in patients with severe gastroesophageal reflux disease. 3) Zollinger-Ellison syndrome Initiate treatment with an initial dose of 2 tablets 3 times daily; the dose may be increased as needed. In severe cases, up to 6 g of ranitidine per day may be administered as directed by a physician. 4) Upper gastrointestinal bleeding due to peptic ulcers, acute stress ulcers, and acute gastric mucosal lesions Once oral administration is possible, switch from injection to oral administration and administer 2 tablets twice daily. 5) Premedication for anesthesia (prevention of Mendelson's syndrome) Administer 2 tablets 2 hours before induction of anesthesia. It is also preferable to administer 2 tablets on the night before surgery.
This medication should not be used in patients with significantly impaired renal function or those undergoing dialysis. It should also not be administered to patients who have had an allergic reaction to this drug or its components. Patients with acute porphyria, a rare disease, should be careful as symptoms may worsen with this medication. Administration should be avoided in patients with poor renal function, who have undergone gastrointestinal surgery, pregnant or potentially pregnant women, premature infants or newborns, and patients following dietary restrictions that limit potassium intake. Patients with liver dysfunction, a history of drug allergies, the elderly, and those with previous kidney issues should be cautious when using this medication. Special care is required when taken with non-steroidal anti-inflammatory drugs, and elderly patients with a history of peptic ulcers need regular monitoring. This medication can mask symptoms of stomach cancer, so patients with gastric ulcers or those newly experiencing indigestion symptoms who are over middle age should confirm that there is no malignant disease before using. Patients with Helicobacter pylori infection causing gastritis or ulcers must undergo therapy to eradicate the bacteria. Serious patients in intensive care units or patients with low levels of phosphate in their bodies, and those who have difficulty swallowing, should also be cautious with this medication. Rarely, serious allergic reactions, such as anaphylactic shock, may occur during treatment, and if symptoms arise, administration should be stopped immediately and medical attention sought. Cutaneous rashes, urticaria, and respiratory distress may occur, and in such cases, medication should also be discontinued. Abnormalities in blood tests might be observed, so if symptoms like general malaise, bleeding, or fever occur, it is essential to consult a doctor immediately. If liver dysfunction symptoms or jaundice appear, use should be stopped right away. Circulatory system abnormalities like cardiac arrhythmias or vasculitis have also been reported very rarely. Gastrointestinal symptoms such as nausea, vomiting, and abdominal pain may occur, and stool color may change, but in most cases, treatment is not necessary. Neurological symptoms such as dizziness, drowsiness, confusion, and seizures may appear, so caution is required, especially for patients with reduced kidney function. Rarely, hormone-related symptoms such as gynecomastia and erectile dysfunction have been reported. If muscle pain or joint pain occurs, it is essential to consult healthcare professionals, and skin rashes or hair loss may also occur infrequently. It is advisable not to use this medication for a long time, and if there is no therapeutic effect, switching to another drug is recommended. Blood tests and regular examinations of liver and kidney function should be performed periodically to monitor for abnormalities. The elderly, patients with chronic lung diseases, diabetes, and those with weakened immune systems may have an increased risk of pneumonia, requiring caution. If dizziness or drowsiness is experienced during use, it is advisable to avoid driving or operating hazardous machinery. This medication may interact with other drugs, so it is crucial to inform your doctor or pharmacist of any medications you are currently taking. Especially when taking medications that affect blood coagulation, careful monitoring through blood tests is essential. Additionally, some antibiotics or anticonvulsants used concurrently can affect absorption, so dosing intervals may need to be adjusted. It is safest for pregnant or potentially pregnant women and breastfeeding mothers to avoid this medication. Safety and efficacy in children have not been sufficiently established, so its use is not recommended. In cases of overdose, emergency measures such as vomiting or gastric lavage may be necessary, and in some instances, blood dialysis may be required. This medication reduces gastric acid secretion, which can lead to an increase in gastric bacteria if used for extended periods, so regular evaluations, including ocular examinations, may be needed during prolonged use.
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a tightly sealed container to prevent exposure to air and moisture, and it is recommended to be kept at room temperature between 1°C and 30°C. Proper storage helps maintain the medication's efficacy for a longer duration and prevents deterioration.
This medication is a round, white film-coated tablet.
30 tablets/bottle, 300 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowCombinationRanitidine Hydrochloride 84mg · Tripotassium Bismuth Dicitrate 100mg +1 more
Tablet · Prescription medication · Combination
Ilhwa Co., Ltd.
CombinationRanitidine Hydrochloride 84mg · Tripotassium Bismuth Dicitrate 100mg +1 more
Tablet · Prescription medication · Combination
Daewoong Pharmaceutical Co., Ltd.
Ranitidine Hydrochloride 84mg · Tripotassium Bismuth Dicitrate 100mg +1 more
Tablet · Prescription medication · Combination
Nexpharm Korea Co., Ltd.
CombinationRanitidine Hydrochloride 84mg · Tripotassium Bismuth Dicitrate 100mg +1 more
Tablet · Prescription medication · Combination
HUONS BioScience Co., Ltd.
CombinationRanitidine Hydrochloride 84mg · Tripotassium Bismuth Dicitrate 100mg +1 more
Tablet · Prescription medication · Combination
Daewoong Bio Co., Ltd.
CombinationRanitidine Hydrochloride 84mg · Tripotassium Bismuth Dicitrate 100mg +1 more
Tablet · Prescription medication · Combination
Teragen Etex Co., Ltd.
Ranitidine Hydrochloride 84mg · Sucralfate Hydrate 300mg +1 more
Tablet · Prescription medication · Combination
Korea Pavise Pharmaceutical Co., Ltd.
Ranitidine Hydrochloride 84mg · Sucralfate Hydrate 300mg +1 more
Tablet · Prescription medication · Combination
Kwangdong Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.